Northland Securities Lifts Earnings Estimates for Camtek

Key Points

• Northland Securities raised Camtek’s Q3 2026 EPS estimate to $0.93 from $0.91 and projects $3.35 EPS for FY2026 and $4.60 for FY2027. Analysts overall rate the stock “Moderate Buy,” with a consensus price target of $176.75.
• Camtek’s latest quarter exceeded expectations, reporting $0.78 EPS versus the $0.76 consensus and $133.24 million in revenue, up 8% year over year. Management’s outlook points to strong demand from advanced semiconductor packaging and AI-related chip production.
• Valuation and recent trading remain concerns: Shares opened at $131.38, well below their 50-day and 200-day moving averages, while the company trades at a P/E ratio above 200. Insiders have also sold more than $4.5 million of stock over the past quarter.

Camtek Ltd. (NASDAQ:CAMT - Free Report) - Investment analysts at Northland Securities lifted their Q3 2026 earnings per share estimates for Camtek in a research report issued to clients and investors on Thursday, October 15th. Northland Securities analyst G. Richard now forecasts that the semiconductor company will post earnings of $0.93 per share for the quarter, up from their previous forecast of $0.91. The consensus estimate for Camtek's current full-year earnings is $3.27 per share. Northland Securities also issued estimates for Camtek's Q4 2026 earnings at $1.09 EPS, FY2026 earnings at $3.35 EPS, Q1 2027 earnings at $1.11 EPS, Q2 2027 earnings at $1.15 EPS, Q3 2027 earnings at $1.16 EPS, Q4 2027 earnings at $1.18 EPS and FY2027 earnings at $4.60 EPS.

A number of other equities research analysts have also recently issued reports on CAMT. Cantor Fitzgerald restated a "neutral" rating and issued a $175.00 price objective on shares of Camtek in a research note on Tuesday, September 22nd. Morgan Stanley cut their target price on shares of Camtek from $165.00 to $152.00 and set an "equal weight" rating for the company in a research report on Monday, September 28th. Weiss Ratings reiterated a "hold (c)" rating on shares of Camtek in a research report on Tuesday, August 11th. Finally, Stifel Nicolaus set a $170.00 target price on shares of Camtek in a research note on Monday, August 10th. Seven equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $176.75.

Camtek Trading Down 3.2%

Shares of CAMT opened at $131.38 on Friday. The business has a 50-day moving average of $148.57 and a 200 day moving average of $160.41. Camtek has a fifty-two week low of $91.91 and a fifty-two week high of $215.99. The firm has a market cap of $6.13 billion, a P/E ratio of 205.28, a price-to-earnings-growth ratio of 2.92 and a beta of 1.56. The company has a debt-to-equity ratio of 0.69, a quick ratio of 6.58 and a current ratio of 7.38.

Camtek (NASDAQ:CAMT - Get Free Report) last issued its quarterly earnings results on Monday, August 10th. The semiconductor company reported $0.78 EPS for the quarter, beating analysts' consensus estimates of $0.76 by $0.02. The firm had revenue of $133.24 million for the quarter, compared to analysts' expectations of $130.44 million. Camtek had a return on equity of 21.58% and a net margin of 7.40%. The business's revenue for the quarter was up 8.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.79 EPS.

Institutional Trading of Camtek

A number of institutional investors have recently added to or reduced their stakes in the stock. IFP Advisors Inc boosted its stake in Camtek by 576.7% in the 2nd quarter. IFP Advisors Inc now owns 203 shares of the semiconductor company's stock worth $33,000 after purchasing an additional 173 shares during the period. Fifth Third Bancorp bought a new stake in shares of Camtek during the first quarter valued at about $42,000. EverSource Wealth Advisors LLC increased its position in shares of Camtek by 46.8% during the first quarter. EverSource Wealth Advisors LLC now owns 298 shares of the semiconductor company's stock valued at $45,000 after buying an additional 95 shares during the period. Compass Financial Management LLC purchased a new stake in shares of Camtek in the second quarter worth about $57,000. Finally, Caitong International Asset Management Co. Ltd purchased a new stake in shares of Camtek in the fourth quarter worth about $63,000. Hedge funds and other institutional investors own 41.93% of the company's stock.

Insider Activity

In other news, VP Orit Geva-Dvash sold 508 shares of Camtek stock in a transaction on Monday, August 17th. The stock was sold at an average price of $175.00, for a total value of $88,900.00. Following the completion of the transaction, the vice president directly owned 5,205 shares in the company, valued at approximately $910,875. The trade was a 8.89% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Rafi Amit sold 6,250 shares of Camtek stock in a transaction on Thursday, August 13th. The shares were sold at an average price of $170.52, for a total value of $1,065,750.00. Following the completion of the transaction, the chief executive officer owned 55,350 shares of the company's stock, valued at approximately $9,438,282. This trade represents a 10.15% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 26,843 shares of company stock valued at $4,514,249. 79.40% of the stock is currently owned by corporate insiders.

Key Camtek News

Here are the key news stories impacting Camtek this week:

• Positive Sentiment: Record growth outlook: Camtek expects third-quarter 2026 revenue of $160–$161 million, slightly above prior guidance and up approximately 27% year over year. It also issued record fourth-quarter guidance of $180 million and raised full-year 2026 revenue guidance to about $595 million. Camtek Q3 and 2027 outlook
• Positive Sentiment: 2027 outlook significantly exceeds expectations: Initial 2027 revenue guidance of more than $800 million is well above analyst estimates ranging from roughly $749 million to $756 million. The outlook reflects continued demand for inspection and metrology equipment used in advanced semiconductor packaging, particularly AI chips. Camtek 2027 revenue outlook
• Positive Sentiment: AI exposure supports long-term demand: Management’s investor-day commentary highlighted strong demand tied to advanced packaging and AI-related semiconductor production, reinforcing the company’s growth narrative. Camtek AI packaging outlook
• Neutral Sentiment: The guidance upgrades are modest for the remainder of 2026—third-quarter revenue is only slightly above prior expectations, while full-year guidance is close to consensus—so the main upside surprise is concentrated in the 2027 forecast.
• Negative Sentiment: Valuation remains a major concern: With a market capitalization around $6.1–$6.3 billion and a reported P/E ratio above 200, investors may view much of the AI-driven growth as already reflected in CAMT’s price. Analysts and commentary characterized the stock as potentially expensive even after the record outlook. Camtek valuation and AI growth

Camtek Company Profile

Camtek Ltd. NASDAQ: CAMT is an Israel-based provider of inspection and metrology systems used in semiconductor manufacturing. The company develops equipment and software designed to identify defects, measure wafer and package characteristics, and support process control during the production of integrated circuits.

Camtek's product portfolio serves a range of applications, including advanced packaging, heterogeneous integration, chiplets, memory, foundry and logic manufacturing, and other high-density semiconductor processes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.